Literature DB >> 8362905

Decrease in thyrocalcitonin-containing cells and analysis of other congenital anomalies in 11 patients with DiGeorge anomaly.

J Palacios1, C Gamallo, M García, J I Rodríguez.   

Abstract

Experimental studies have demonstrated that the DiGeorge anomaly is due to cranial neural crest abnormalities. In the present study, the quantitation of thyrocalcitonin immunoreactive cells (C-cells) has been used to evaluate whether cells derived from the cranial neural crest are or are not present in normal proportions in patients with this anomaly. Thyroid sections from 11 such patients and 11 control patients were studied immunohistochemically at autopsy in order to determine the number and distribution of thyrocalcitonin-containing cells. Patients with DiGeorge anomaly showed thymic and parathyroid aplasia/hypoplasia and cardiovascular defects, such as type B interrupted aortic arch, truncus arteriosus and tetralogy of Fallot. Other associated defects were alobar holoprosencephaly and meningocele (previously unreported defects in this anomaly), arhinencephaly, renal cystic dysplasia, ureterohydronephrosis, esophageal atresia with tracheoesophageal fistula, and cleft lip and palate. The volume density of C-cells (1.187%) and the mean number of C-cells per follicle (1.42) was significantly lower in patients with DiGeorge anomaly than in control patients (3.475% and 2.367, respectively). These results indicate a decrease in cells derived from the neural crest in patients with DiGeorge anomaly, and support the hypothesis of a neural crest disturbance as the pathogenetic factor responsible for this anomaly.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8362905     DOI: 10.1002/ajmg.1320460608

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  6 in total

1.  Renal and urological tract malformations caused by a 22q11 deletion.

Authors:  K Devriendt; A Swillen; J P Fryns; W Proesmans; M Gewillig
Journal:  J Med Genet       Date:  1996-04       Impact factor: 6.318

2.  Chromosome 22q11 deletion presenting as the Potter sequence.

Authors:  K Devriendt; P Moerman; D Van Schoubroeck; K Vandenberghe; J P Fryns
Journal:  J Med Genet       Date:  1997-05       Impact factor: 6.318

3.  Neural tube defects and atypical deletion on 22q11.2.

Authors:  Chiara Leoni; David A Stevenson; Katherine B Geiersbach; Christian N Paxton; Bryan L Krock; Rong Mao; Alan F Rope
Journal:  Am J Med Genet A       Date:  2014-08-13       Impact factor: 2.802

4.  A mother with VCFS and unilateral dysplastic kidney and her fetus with multicystic dysplastic kidneys: additional evidence to support the association of renal malformations and VCFS.

Authors:  P M Czarnecki; D L Van Dyke; S Vats; G L Feldman
Journal:  J Med Genet       Date:  1998-04       Impact factor: 6.318

5.  Decrease of parafollicular thyroid C-cells in experimental esophageal atresia: further evidence of a neural crest pathogenic pathway.

Authors:  L Martinez; M De Ceano-Vivas; S Gonzalez-Reyes; F Hernandez; V Fernandez-Dumont; W M Calonge; E Ruiz; J I Rodriguez; J A Tovar
Journal:  Pediatr Surg Int       Date:  2004-11-27       Impact factor: 1.827

6.  The Prevalence and Distribution of Spina Bifida in a Single Major Referral Center in Malaysia.

Authors:  Adibah Sahmat; Renuka Gunasekaran; Siti W Mohd-Zin; Lohis Balachandran; Meow-Keong Thong; Julia P Engkasan; Dharmendra Ganesan; Zaliha Omar; Abu Bakar Azizi; Azlina Ahmad-Annuar; Noraishah M Abdul-Aziz
Journal:  Front Pediatr       Date:  2017-11-09       Impact factor: 3.418

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.